Treace Medical Concepts, Inc. financial data

Symbol
TMCI on Nasdaq
Location
100 Palmetto Park Place, Ponte Vedra, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 415 % -5.3%
Quick Ratio 110 % +37.6%
Debt-to-equity 100 % +15.3%
Return On Equity -46.8 % +5.59%
Return On Assets -23.4 % +11.9%
Operating Margin -22.4 % +31.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.2M shares +1.58%
Common Stock, Shares, Outstanding 62.3M shares +1.09%
Entity Public Float 310M USD -74.7%
Common Stock, Value, Issued 63K USD +1.61%
Weighted Average Number of Shares Outstanding, Basic 63M shares +1.49%
Weighted Average Number of Shares Outstanding, Diluted 63M shares +1.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 214M USD +7.67%
Research and Development Expense 21.2M USD +12.2%
Selling and Marketing Expense 139M USD -8.34%
General and Administrative Expense 59.1M USD +7.97%
Operating Income (Loss) -47.9M USD +26.3%
Net Income (Loss) Attributable to Parent -49.2M USD +22.8%
Earnings Per Share, Basic 0 USD/shares +22.5%
Earnings Per Share, Diluted 0 USD/shares +22.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.05M USD -55.7%
Marketable Securities, Current 61.2M USD -20.3%
Accounts Receivable, after Allowance for Credit Loss, Current 30.3M USD +18.7%
Inventory, Net 42.4M USD +2.71%
Assets, Current 148M USD -14%
Property, Plant and Equipment, Net 29.7M USD +22.5%
Operating Lease, Right-of-Use Asset 8.04M USD -8.35%
Intangible Assets, Net (Excluding Goodwill) 7.6M USD -11.1%
Goodwill 12.8M USD 0%
Other Assets, Noncurrent 676K USD +363%
Assets 206M USD -8.69%
Accounts Payable, Current 20M USD +10.4%
Employee-related Liabilities, Current 7.06M USD +14.1%
Accrued Liabilities, Current 6.19M USD -54.9%
Liabilities, Current 41.9M USD -5.73%
Operating Lease, Liability, Noncurrent 13.4M USD -17.6%
Other Liabilities, Noncurrent 37K USD 0%
Liabilities 109M USD -4.49%
Accumulated Other Comprehensive Income (Loss), Net of Tax 50K USD
Retained Earnings (Accumulated Deficit) -223M USD -28.2%
Stockholders' Equity Attributable to Parent 97.6M USD -13%
Liabilities and Equity 206M USD -8.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.2M USD
Net Cash Provided by (Used in) Financing Activities -282K USD -52.4%
Net Cash Provided by (Used in) Investing Activities -1.89M USD -150%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 63.1M shares +1.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.02M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.05M USD -55.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.23M USD -6.68%
Deferred Tax Assets, Valuation Allowance 44.1M USD +25.4%
Deferred Tax Assets, Gross 49.3M USD +26.2%
Operating Lease, Liability 16.3M USD -5.48%
Payments to Acquire Property, Plant, and Equipment 3.54M USD -9.78%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -49.1M USD +22.7%
Lessee, Operating Lease, Liability, to be Paid 23.3M USD -9.64%
Property, Plant and Equipment, Gross 49.3M USD +34.9%
Operating Lease, Liability, Current 2.09M USD +432%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.34M USD +139%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.82M USD -37.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.91M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.1M USD -7.25%
Deferred Tax Assets, Operating Loss Carryforwards 28.2M USD +22.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.16M USD +2%
Additional Paid in Capital 322M USD +12.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 200K USD
Depreciation, Depletion and Amortization 2.46M USD +28.9%
Deferred Tax Assets, Net of Valuation Allowance 5.12M USD +34.2%
Share-based Payment Arrangement, Expense 34.7M USD +37.7%
Interest Expense 5.26M USD +0.57%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%